Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.91% Nasdaq Up0.87%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS

2.62 Down 0.03(1.13%) 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 323   15,531   1,018   1,877  
Cost of Revenue -   -   -   -  
Gross Profit 323   15,531   1,018   1,877  
Operating Expenses
Research Development20,962  24,033  21,099  21,450  
Selling General and Administrative12,449  9,463  9,300  9,186  
Non Recurring67  2,633   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (33,155) (20,598) (29,381) (28,759)
Income from Continuing Operations
Total Other Income/Expenses Net(60)6  147  93  
Earnings Before Interest And Taxes(33,215)(20,592)(29,234)(28,666)
Interest Expense870  888  888  880  
Income Before Tax(34,085)(21,480)(30,122)(29,546)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(34,085)(21,480)(30,122)(29,546)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (34,085) (21,480) (30,122) (29,546)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (34,085) (21,480) (30,122) (29,546)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.